Ionis Pharmaceuticals Inc (IONS) stock
IONSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/301% below fair value
$28.01−1.05 (-3.61%)
Close on Nov 16, 2026Market cap $4.65BP/E –Yield –
Ionis Pharmaceuticals total assets
Total assets on the balance sheet at the end of each period.
Ionis Pharmaceuticals's total assets was $2.99B at Jun 30, 2026. For fiscal 2025 it was $3.52B, up 17.3% from the year before. Over ten years it grew 14.0% a year on average. The highest annual figure on record is $3.52B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.52B | +17.3% |
| FY2024 | Dec 31, 2024 | $3.00B | +0.5% |
| FY2023 | Dec 31, 2023 | $2.99B | +18.0% |
| FY2022 | Dec 31, 2022 | $2.53B | -3.0% |
| FY2021 | Dec 31, 2021 | $2.61B | +9.3% |
| FY2020 | Dec 31, 2020 | $2.39B | -26.1% |
| FY2019 | Dec 31, 2019 | $3.23B | +21.2% |
| FY2018 | Dec 31, 2018 | $2.67B | +101.7% |
| FY2017 | Dec 31, 2017 | $1.32B | +45.0% |
| FY2016 | Dec 31, 2016 | $912.47M | -3.7% |
| FY2015 | Dec 31, 2015 | $947.90M | -0.8% |
| FY2014 | Dec 31, 2014 | $955.81M | +12.8% |
| FY2013 | Dec 31, 2013 | $847.16M | +55.2% |
| FY2012 | Dec 31, 2012 | $545.69M | +12.5% |
| FY2011 | Dec 31, 2011 | $484.89M | -11.9% |
| FY2010 | Dec 31, 2010 | $550.48M | -16.2% |
| FY2009 | Dec 31, 2009 | $657.18M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.99B | +0.3% |
| Q1 FY2026 | Mar 31, 2026 | $3.45B | +22.6% |
| Q4 FY2025 | Dec 31, 2025 | $3.52B | +17.3% |
| Q3 FY2025 | Sep 30, 2025 | $3.03B | -1.6% |
| Q2 FY2025 | Jun 30, 2025 | $2.99B | +10.9% |
| Q1 FY2025 | Mar 31, 2025 | $2.81B | +1.8% |
| Q4 FY2024 | Dec 31, 2024 | $3.00B | +0.5% |
| Q3 FY2024 | Sep 30, 2024 | $3.08B | +5.0% |
| Q2 FY2024 | Jun 30, 2024 | $2.69B | -9.4% |
| Q1 FY2024 | Mar 31, 2024 | $2.76B | -4.2% |
| Q4 FY2023 | Dec 31, 2023 | $2.99B | +18.0% |
| Q3 FY2023 | Sep 30, 2023 | $2.93B | +21.1% |
| Q2 FY2023 | Jun 30, 2023 | $2.97B | +21.0% |
| Q1 FY2023 | Mar 31, 2023 | $2.89B | +14.5% |
| Q4 FY2022 | Dec 31, 2022 | $2.53B | -3.0% |
| Q3 FY2022 | Sep 30, 2022 | $2.42B | +0.3% |
| Q2 FY2022 | Jun 30, 2022 | $2.46B | -1.6% |
| Q1 FY2022 | Mar 31, 2022 | $2.52B | +12.0% |
| Q4 FY2021 | Dec 31, 2021 | $2.61B | +9.3% |
| Q3 FY2021 | Sep 30, 2021 | $2.41B | -22.0% |
| Q2 FY2021 | Jun 30, 2021 | $2.50B | -18.9% |
| Q1 FY2021 | Mar 31, 2021 | $2.25B | -27.3% |
| Q4 FY2020 | Dec 31, 2020 | $2.39B | -26.1% |
| Q3 FY2020 | Sep 30, 2020 | $3.10B | +6.9% |
| Q2 FY2020 | Jun 30, 2020 | $3.08B | +7.0% |
| Q1 FY2020 | Mar 31, 2020 | $3.09B | +9.0% |
| Q4 FY2019 | Dec 31, 2019 | $3.23B | +21.2% |
| Q3 FY2019 | Sep 30, 2019 | $2.89B | +28.8% |
| Q2 FY2019 | Jun 30, 2019 | $2.88B | +28.1% |
| Q1 FY2019 | Mar 31, 2019 | $2.84B | +118.2% |
| Q4 FY2018 | Dec 31, 2018 | $2.67B | +101.7% |
| Q3 FY2018 | Sep 30, 2018 | $2.25B | +79.5% |
| Q2 FY2018 | Jun 30, 2018 | $2.25B | +106.0% |
| Q1 FY2018 | Mar 31, 2018 | $1.30B | +19.9% |
| Q4 FY2017 | Dec 31, 2017 | $1.32B | +45.0% |
| Q3 FY2017 | Sep 30, 2017 | $1.25B | +48.5% |
| Q2 FY2017 | Jun 30, 2017 | $1.09B | – |
| Q1 FY2017 | Mar 31, 2017 | $1.08B | – |
| Q4 FY2016 | Dec 31, 2016 | $912.47M | – |
| Q3 FY2016 | Sep 30, 2016 | $843.59M | – |
See a number that looks wrong?